Physician profile
Jose Prieto
NPI 1215931878
$1,791.88
in general payments reported to CMS, 2019-2025
20 companies · $518 in 2025
The $518 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $149 · 2021: $59.06 · 2022: $175 · 2023: $236 · 2024: $200 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $336.61 | 2019-2025 | |
| Corium, LLC | $232.25 | 2022-2025 | Azstarys, Azstarys |
| Sanofi Pasteur INC. | $196.65 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $189.06 | 2019-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Sanofi-Aventis U.S. LLC | $145.03 | 2025 | |
| Glaxosmithkline, LLC. | $131.27 | 2019-2023 | Bexsero, Rotarix, Pediarix |
| Ironshore Pharmaceuticals INC. | $95.25 | 2022-2024 | Jornay Pm |
| Seqirus USA INC | $92.44 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Neurelis, INC. | $68.77 | 2020-2023 | Valtoco |
| Tris Pharma INC | $55.62 | 2019-2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $47.94 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $36.30 | 2021-2022 | |
| Abbvie INC. | $33.84 | 2021-2024 | |
| Acadia Pharmaceuticals INC | $27.70 | 2025 | Daybue |
| Ferring Pharmaceuticals INC. | $21.85 | 2023 | Rebyota |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $21.51 | 2019 | |
| Inspire Medical Systems, INC. | $18.58 | 2023 | Inspire |
| Vertical Pharmaceuticals, LLC | $14.35 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.34 | 2024 | Kristalose |
| Biomarin Pharmaceutical INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Prieto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.